(Q34090592)

30 July 2017

title

Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or concepts (English)

1 reference

30 July 2017

main subject

phase III clinical trial

0 references

author name string

Peter B Gilbert

series ordinal

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

30 July 2017

published in

Statistics in Medicine

1 reference

30 July 2017

volume

29

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

1061-1071

1 reference

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2929839

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2929839

Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2929839

Low-efficacy HIV vaccines: potential for community-based intervention programmes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2929839

HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2929839

Some design issues in trials of microbicides for the prevention of HIV infection

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FSIM.3676

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FSIM.3676

A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FSIM.3676

A strategy for accelerating the development of preventive AIDS vaccines

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20419758

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/SIM.3676

1 reference

30 July 2017

1 reference

30 July 2017

1 reference